Clinical Updates

The European Medicines Agency could be leaderless for much of next year, after a series of missteps and a row… »   

A closer look at data from a late stage trial of Vertex Pharmaceuticals Inc’s eagerly anticipated hepatitis C drug… »   

FDA’s complete response letter on Qnexa was probably the best Vivus (VVUS) could have hoped for. Given the negative news… »   

AMAG Pharmaceuticals’ shares fell 21 percent to their lowest in nearly five years after it found “life-threatening” events associated… »   

Pfizer Inc is recalling two more lots of Lipitor, the world’s largest selling prescription drug, after chemicals used in wooden… »   

Millions of Medicare recipients have been forcibly reassigned to different prescription drug plans because Part D reimbursements to insurance companies… »   

Hope for a new prescription weight-loss pill bit the dust over the weekend when the FDA rejected lorcaserin, calling any… »   

British pharmaceutical company GlaxoSmithKline will pay $750 million to settle allegations that it knowingly manufactured and sold adulterated drugs, including… »   

Teens should get a booster dose of the vaccine for bacterial meningitis because a single shot doesn’t work as long… »   

A new double-strain polio vaccine is more effective than triple and single vaccines and will be a potent weapon in… »   

Trying a new, experimental cancer drug may offer a glimpse of hope for very sick patients, but often does more… »   

Ariad Pharmaceuticals said its experimental treatment for advanced uterine cancer was more effective than standard treatment in a mid-stage trial,… »   

Switzerland’s innovative policy of providing drug addicts with free methadone and clean needles has greatly reduced deaths while cutting crime… »   

A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests.

Researchers… »   

GlaxoSmithKline has cut the price of its cervical cancer vaccine Cervarix by 30 percent in Canada in a bid to… »